11:55:25 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-06-18 Bokslutskommuniké 2024
2024-03-13 Kvartalsrapport 2024-Q3
2023-12-12 Kvartalsrapport 2024-Q2
2023-10-18 Ordinarie utdelning SDOS 0.00 SEK
2023-10-17 Årsstämma 2024
2023-09-13 Kvartalsrapport 2024-Q1
2023-06-15 Bokslutskommuniké 2023
2023-03-08 Kvartalsrapport 2023-Q3
2022-12-07 Kvartalsrapport 2023-Q2
2022-10-18 Ordinarie utdelning SDOS 0.00 SEK
2022-10-17 Årsstämma 2023
2022-09-13 Kvartalsrapport 2023-Q1
2022-06-28 Bokslutskommuniké 2022
2022-03-11 Kvartalsrapport 2022-Q3
2021-12-14 Kvartalsrapport 2022-Q2
2021-10-21 Ordinarie utdelning SDOS 0.00 SEK
2021-10-20 Årsstämma 2022
2021-09-23 Kvartalsrapport 2022-Q1
2021-06-29 Bokslutskommuniké 2021
2021-03-10 Kvartalsrapport 2021-Q3
2020-12-16 Kvartalsrapport 2021-Q2
2020-10-07 Ordinarie utdelning SDOS 0.00 SEK
2020-10-06 Årsstämma 2021
2020-09-25 Kvartalsrapport 2021-Q1
2020-06-26 Bokslutskommuniké 2020
2020-03-10 Kvartalsrapport 2020-Q3
2019-12-18 Kvartalsrapport 2020-Q2
2019-10-09 Ordinarie utdelning SDOS 0.00 SEK
2019-10-08 Årsstämma 2020
2019-09-12 Kvartalsrapport 2020-Q1
2019-06-28 Bokslutskommuniké 2019
2018-12-14 Kvartalsrapport 2019-Q2
2018-10-03 Ordinarie utdelning SDOS 0.00 SEK
2018-10-02 Årsstämma 2019
2018-06-28 Bokslutskommuniké 2018
2018-03-22 Kvartalsrapport 2018-Q3
2017-12-15 Kvartalsrapport 2018-Q2
2017-10-03 Ordinarie utdelning SDOS 0.00 SEK
2017-10-02 Årsstämma 2018
2017-09-29 Kvartalsrapport 2018-Q1
2017-06-28 Bokslutskommuniké 2017
2017-03-22 Kvartalsrapport 2017-Q3
2016-12-15 Kvartalsrapport 2017-Q2
2016-09-21 Ordinarie utdelning SDOS 0.00 SEK
2016-09-20 Kvartalsrapport 2017-Q1
2016-09-20 Årsstämma 2017
2016-06-30 Bokslutskommuniké 2016
2016-03-15 Kvartalsrapport 2016-Q3
2015-12-11 Kvartalsrapport 2016-Q2
2015-09-24 Ordinarie utdelning SDOS 0.00 SEK
2015-09-23 Årsstämma 2016
2015-09-23 Kvartalsrapport 2016-Q1
2015-06-23 Bokslutskommuniké 2015
2015-03-26 Kvartalsrapport 2015-Q3
2014-12-19 Kvartalsrapport 2015-Q2
2014-10-14 Årsstämma 2015
2014-09-24 Ordinarie utdelning SDOS 0.00 SEK
2014-09-23 Kvartalsrapport 2015-Q1
2014-06-13 Bokslutskommuniké 2014

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Scandidos är verksamt inom medicinteknik. Bolaget erbjuder produkter och system för kvalitetssäkring av avancerad strålterapi mot cancer. Systemen analyserar stråldosen inför och under pågående strålbehandling. Bolaget grundades under 2002 och den första produkten lanserades 2006. Sedan starten har Scandidos levererat produkter till strålterapikliniker på global nivå. Huvudkontoret ligger i Uppsala.
2024-04-18 13:00:00

ScandiDos, renowned for its advanced QA solutions in radiotherapy, recently participated in a well-attended user meeting in Spain. The event served as a platform for active discussions and knowledge exchange, with a particular focus on quality assurance for moving targets in radiotherapy. With inspiring speakers and an engaged participant base, the meeting highlighted the importance of innovative medical technology in advancing cancer patient care.

ScandiDos' user meeting was organized by the company's local distributor, Fimecorp International S.L., and targeted both existing and potential users of ScandiDos' QA solutions. The event brought together clinical experts and medical physicists from across the country to share insights and experiences with ScandiDos' groundbreaking measurement phantom, Delta4 Phantom+. Delta4 Phantom+ is ScandiDos' most sought-after product and is used in quality assurance of cancer treatments at over 800 cancer clinics worldwide.

With over 50 participants actively engaging in discussions and sharing their expertise, the user meeting provided an ideal forum for enriching understanding within the field. Held at Central Hospital De La Defensa Gómez Ulla, the meeting featured demonstrations of ScandiDos products in a clinical environment. Among other things, the hospital showcased its process for quality assurance of treatments for moving targets using Delta4 Phantom+ along with ScandiDos' motion platform, Delta4 Hexamotion. Quality assurance for moving targets is crucial as it ensures that radiotherapy treatments are accurate and effective even when the tumor moves due to the patient's breathing or movements, thereby reducing the risk of damage to surrounding tissues and improving treatment outcomes.

“The user meeting proved exceptionally valuable as clinicians actively shared insights and results. We are delighted with the positive feedback on our products and are grateful for the development suggestions we received. These requests will guide us in developing solutions to meet our customers' varying needs even better. Engaging with such a dedicated group of users was truly inspiring," says Gustaf Piehl, CEO of ScandiDos.